RE:RE:RE:RE:RE:RE:RE:RE:Fia did not acquire any shares but granted himself options.....and they're not a startup. They were formed in 2001 if you didn't know. They have other products and the Venowave just got a minimum $10 million sales per year contract. He should get options and bonus for that alone. When they get FDA approval and contracts he should get more. Rob has stated that sales ia not their problem, interest is very high. The problem they envisioned was being able to keep up with demand.